Works by Laher, Fatima

Results: 48
    1

    Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials.

    Published in:
    PLoS Medicine, 2020, v. 17, n. 5, p. 1, doi. 10.1371/journal.pmed.1003117
    By:
    • Moodie, Zoe;
    • Walsh, Stephen R.;
    • Laher, Fatima;
    • Maganga, Lucas;
    • Herce, Michael E.;
    • Naidoo, Sarita;
    • Hosseinipour, Mina C.;
    • Innes, Craig;
    • Bekker, Linda-Gail;
    • Grunenberg, Nicole;
    • Mann, Philipp;
    • Yu, Chenchen;
    • deCamp, Allan C.;
    • Miner, Maurine D.;
    • Yates, Nicole L.;
    • Heptinstall, Jack;
    • Mkhize, Nonhlanhla N.;
    • Dintwe, One;
    • Frahm, Nicole;
    • Cohen, Kristen W.
    Publication type:
    Article
    2

    Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials.

    Published in:
    2020
    By:
    • Moodie, Zoe;
    • Walsh, Stephen R;
    • Laher, Fatima;
    • Maganga, Lucas;
    • Herce, Michael E;
    • Naidoo, Sarita;
    • Hosseinipour, Mina C;
    • Innes, Craig;
    • Bekker, Linda-Gail;
    • Grunenberg, Nicole;
    • Mann, Philipp;
    • Yu, Chenchen;
    • deCamp, Allan C;
    • Miner, Maurine D;
    • Yates, Nicole L;
    • Heptinstall, Jack;
    • Mkhize, Nonhlanhla N;
    • Dintwe, One;
    • Frahm, Nicole;
    • Cohen, Kristen W
    Publication type:
    journal article
    3
    4

    ALVAC-prime and monomeric gp120 protein boost induces distinct HIV-1 specific humoral and cellular responses compared with adenovirus-prime and trimeric gp140 protein boost.

    Published in:
    PLoS Global Public Health, 2025, v. 5, n. 4, p. 1, doi. 10.1371/journal.pgph.0004250
    By:
    • Fisher, Leigh H.;
    • Lazarus, Erica;
    • Yu, Chenchen;
    • Moodie, Zoe;
    • Stieh, Daniel J.;
    • Yates, Nicole;
    • Zhang, Lu;
    • Sawant, Sheetal;
    • De Rosa, Stephen C.;
    • Cohen, Kristen W.;
    • Morris, Daryl;
    • Grant, Shannon;
    • Randhawa, April;
    • Miner, Maurine D.;
    • Hendriks, Jenny;
    • Wegmann, Frank;
    • Gill, Katherine M.;
    • Laher, Fatima;
    • Bekker, Linda-Gail;
    • Gray, Glenda E.
    Publication type:
    Article
    5
    6
    7

    Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature.

    Published in:
    Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-69007-w
    By:
    • Palli, Rohith;
    • Seaton, Kelly E.;
    • Piepenbrink, Michael S.;
    • Hural, John;
    • Goepfert, Paul A.;
    • Laher, Fatima;
    • Buchbinder, Susan P.;
    • Churchyard, Gavin;
    • Gray, Glenda E.;
    • Robinson, Harriet L.;
    • Huang, Yunda;
    • Janes, Holly;
    • Kobie, James J.;
    • Keefer, Michael C.;
    • Tomaras, Georgia D.;
    • Thakar, Juilee
    Publication type:
    Article
    8
    9
    10

    Vaccine-Induced Antibodies Mediate Higher Antibody-Dependent Cellular Cytotoxicity After Interleukin-15 Pretreatment of Natural Killer Effector Cells.

    Published in:
    Frontiers in Immunology, 2019, v. 10, p. 1, doi. 10.3389/fimmu.2019.02741
    By:
    • Fisher, Leigh;
    • Zinter, Melissa;
    • Stanfield-Oakley, Sherry;
    • Carpp, Lindsay N.;
    • Edwards, R. Whitney;
    • Denny, Thomas;
    • Moodie, Zoe;
    • Laher, Fatima;
    • Bekker, Linda-Gail;
    • McElrath, M. Juliana;
    • Gilbert, Peter B.;
    • Corey, Lawrence;
    • Tomaras, Georgia;
    • Pollara, Justin;
    • Ferrari, Guido
    Publication type:
    Article
    11
    12

    Protein Dose-Sparing Effect of AS01<sub>B</sub> Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVAC-HIV (vCP2438) and Adjuvanted Bivalent Subtype C gp120.

    Published in:
    Journal of Infectious Diseases, 2024, v. 230, n. 2, p. e405, doi. 10.1093/infdis/jiad434
    By:
    • Chirenje, Zvavahera Mike;
    • Laher, Fatima;
    • Dintwe, One;
    • Muyoyeta, Monde;
    • deCamp, Allan C;
    • He, Zonglin;
    • Grunenberg, Nicole;
    • Omar, Faatima Laher;
    • Seaton, Kelly E;
    • Polakowski, Laura;
    • Davis, Amanda S Woodward;
    • Maganga, Lucas;
    • Baden, Lindsey R;
    • Mayer, Kenneth;
    • Kalams, Spyros;
    • Keefer, Michael;
    • Edupuganti, Srilatha;
    • Rodriguez, Benigno;
    • Frank, Ian;
    • Scott, Hyman
    Publication type:
    Article
    13

    Analysis of the HIV Vaccine Trials Network 702 Phase 2b-3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk.

    Published in:
    2022
    By:
    • Moodie, Zoe;
    • Dintwe, One;
    • Sawant, Sheetal;
    • Grove, Doug;
    • Huang, Yunda;
    • Janes, Holly;
    • Heptinstall, Jack;
    • Omar, Faatima Laher;
    • Cohen, Kristen;
    • Rosa, Stephen C De;
    • Zhang, Lu;
    • Yates, Nicole L;
    • Sarzotti-Kelsoe, Marcella;
    • Seaton, Kelly E;
    • Laher, Fatima;
    • Bekker, Linda Gail;
    • Malahleha, Mookho;
    • Innes, Craig;
    • Kassim, Sheetal;
    • Naicker, Nivashnee
    Publication type:
    journal article
    14

    Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk.

    Published in:
    PLoS Pathogens, 2021, p. 1, doi. 10.1371/journal.ppat.1009363
    By:
    • Andersen-Nissen, Erica;
    • Fiore-Gartland, Andrew;
    • Ballweber Fleming, Lamar;
    • Carpp, Lindsay N.;
    • Naidoo, Anneta F.;
    • Harper, Michael S.;
    • Voillet, Valentin;
    • Grunenberg, Nicole;
    • Laher, Fatima;
    • Innes, Craig;
    • Bekker, Linda-Gail;
    • Kublin, James G.;
    • Huang, Ying;
    • Ferrari, Guido;
    • Tomaras, Georgia D.;
    • Gray, Glenda;
    • Gilbert, Peter B.;
    • McElrath, M. Juliana
    Publication type:
    Article
    15
    16
    17

    HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens.

    Published in:
    Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-57491-z
    By:
    • Shen, Xiaoying;
    • Laher, Fatima;
    • Moodie, Zoe;
    • McMillan, Arthur S.;
    • Spreng, Rachel L.;
    • Gilbert, Peter B.;
    • Huang, Ying;
    • Yates, Nicole L.;
    • Grunenberg, Nicole;
    • Juliana McElrath, M.;
    • Allen, Mary;
    • Pensiero, Michael;
    • Mehra, Vijay L.;
    • Der Meeren, Olivier Van;
    • Barnett, Susan W.;
    • Phogat, Sanjay;
    • Gray, Glenda E.;
    • Bekker, Linda-Gail;
    • Corey, Lawrence;
    • Tomaras, Georgia D.
    Publication type:
    Article
    18

    Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa.

    Published in:
    Science Translational Medicine, 2019, v. 11, n. 510, p. 1, doi. 10.1126/scitranslmed.aax1880
    By:
    • Gray, Glenda E.;
    • Huang, Ying;
    • Grunenberg, Nicole;
    • Laher, Fatima;
    • Roux, Surita;
    • Andersen-Nissen, Erica;
    • De Rosa, Stephen C.;
    • Flach, Britta;
    • Randhawa, April K.;
    • Jensen, Ryan;
    • Swann, Edith M.;
    • Bekker, Linda-Gail;
    • Innes, Craig;
    • Lazarus, Erica;
    • Morris, Lynn;
    • Mkhize, Nonhlanhla N.;
    • Ferrari, Guido;
    • Montefiori, David C.;
    • Shen, Xiaoying;
    • Sawant, Sheetal
    Publication type:
    Article
    19
    20
    21
    22
    23

    Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.

    Published in:
    PLoS Medicine, 2024, v. 21, n. 3, p. 1, doi. 10.1371/journal.pmed.1004360
    By:
    • Moodie, Zoe;
    • Andersen-Nissen, Erica;
    • Grunenberg, Nicole;
    • Dintwe, One B.;
    • Omar, Faatima Laher;
    • Kee, Jia J.;
    • Bekker, Linda-Gail;
    • Laher, Fatima;
    • Naicker, Nivashnee;
    • Jani, Ilesh;
    • Mgodi, Nyaradzo M.;
    • Hunidzarira, Portia;
    • Sebe, Modulakgota;
    • Miner, Maurine D.;
    • Polakowski, Laura;
    • Ramirez, Shelly;
    • Nebergall, Michelle;
    • Takuva, Simbarashe;
    • Sikhosana, Lerato;
    • Heptinstall, Jack
    Publication type:
    Article
    24
    25
    26

    Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa.

    Published in:
    AIDS & Behavior, 2023, v. 27, n. 9, p. 3027, doi. 10.1007/s10461-023-04025-z
    By:
    • Malahleha, Mookho;
    • Laher, Fatima;
    • Dilraj, Athmanundh;
    • Smith, Philip;
    • Gray, Glenda E.;
    • Grove, Doug;
    • Odhiambo, Jackline A.;
    • Andrasik, Michele P.;
    • Grunenberg, Nicole A.;
    • Moodie, Zoe;
    • Huang, Yunda;
    • Borate, Bhavesh R.;
    • Gillespie, Kevin M.;
    • Allen, Mary;
    • Atujuna, Millicent;
    • Singh, Nishanta;
    • Kalonji, Dishiki;
    • Meintjes, Graeme;
    • Kotze, Phillip;
    • Bekker, Linda-Gail
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33

    Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses.

    Published in:
    Viruses (1999-4915), 2024, v. 16, n. 9, p. 1365, doi. 10.3390/v16091365
    By:
    • Huang, Ying;
    • Alam, Shomoita;
    • Andersen-Nissen, Erica;
    • Carpp, Lindsay N.;
    • Dintwe, One B.;
    • Flach, Britta S.;
    • Grunenberg, Nicole;
    • Laher, Fatima;
    • De Rosa, Stephen C.;
    • Ferrari, Guido;
    • Innes, Craig;
    • Bekker, Linda-Gail;
    • Kublin, James G.;
    • McElrath, M. Juliana;
    • Tomaras, Georgia D.;
    • Gray, Glenda E.;
    • Gilbert, Peter B.
    Publication type:
    Article
    34

    Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men.

    Published in:
    PLoS ONE, 2015, v. 10, n. 9, p. 1, doi. 10.1371/journal.pone.0137666
    By:
    • Moodie, Zoe;
    • Metch, Barbara;
    • Bekker, Linda-Gail;
    • Churchyard, Gavin;
    • Nchabeleng, Maphoshane;
    • Mlisana, Koleka;
    • Laher, Fatima;
    • Roux, Surita;
    • Mngadi, Kathryn;
    • Innes, Craig;
    • Mathebula, Matsontso;
    • Allen, Mary;
    • Bentley, Carter;
    • Gilbert, Peter B.;
    • Robertson, Michael;
    • Kublin, James;
    • Corey, Lawrence;
    • Gray, Glenda E.
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41

    Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines.

    Published in:
    2020
    By:
    • Laher, Fatima;
    • Moodie, Zoe;
    • Cohen, Kristen W.;
    • Grunenberg, Nicole;
    • Bekker, Linda-Gail;
    • Allen, Mary;
    • Frahm, Nicole;
    • Yates, Nicole L.;
    • Morris, Lynn;
    • Malahleha, Mookho;
    • Mngadi, Kathryn;
    • Daniels, Brodie;
    • Innes, Craig;
    • Saunders, Kevin;
    • Grant, Shannon;
    • Yu, Chenchen;
    • Gilbert, Peter B.;
    • Phogat, Sanjay;
    • DiazGranados, Carlos A.;
    • Koutsoukos, Marguerite
    Publication type:
    journal article
    42
    43
    44
    45
    46
    47
    48